Although previous studies have been dedicated to treating HGPS by halting farnesylation via FTase inhibitors, Ibrahim et al. targeted Icmt expression as a means to reverse progeria-like symptoms in a mouse model of HGPS (Ibrahim et al., 2013). This evidence concerns the gene LMNA and progeroid syndrome.